David E. Joyner

428 total citations
37 papers, 344 citations indexed

About

David E. Joyner is a scholar working on Pulmonary and Respiratory Medicine, Ecology and Molecular Biology. According to data from OpenAlex, David E. Joyner has authored 37 papers receiving a total of 344 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Pulmonary and Respiratory Medicine, 13 papers in Ecology and 11 papers in Molecular Biology. Recurrent topics in David E. Joyner's work include Sarcoma Diagnosis and Treatment (13 papers), Avian ecology and behavior (9 papers) and Molecular Biology Techniques and Applications (5 papers). David E. Joyner is often cited by papers focused on Sarcoma Diagnosis and Treatment (13 papers), Avian ecology and behavior (9 papers) and Molecular Biology Techniques and Applications (5 papers). David E. Joyner collaborates with scholars based in United States, India and Canada. David E. Joyner's co-authors include R. Lor Randall, Karen Albritton, Robert D. Arthur, Timothy A. Damron, Kevin L. Knudtson, Albert J. Aboulafia, Ying J. Hitchcock, Mark Wade, Hong Mu and Cheryl M. Coffin and has published in prestigious journals such as Journal of Colloid and Interface Science, Infection and Immunity and Clinical Orthopaedics and Related Research.

In The Last Decade

David E. Joyner

34 papers receiving 264 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David E. Joyner United States 11 153 71 70 60 48 37 344
Michael J. Imber United States 14 373 2.4× 23 0.3× 85 1.2× 71 1.2× 39 0.8× 41 672
PM Johnson United Kingdom 14 211 1.4× 24 0.3× 23 0.3× 56 0.9× 31 0.6× 35 557
Stephen G. Martin United States 12 184 1.2× 36 0.5× 62 0.9× 38 0.6× 121 2.5× 23 452
Keisuke Nakata Japan 10 254 1.7× 22 0.3× 90 1.3× 175 2.9× 55 1.1× 32 686
A J Baker United Kingdom 14 258 1.7× 54 0.8× 68 1.0× 211 3.5× 91 1.9× 28 849
Michael T. Henderson United States 9 171 1.1× 60 0.8× 109 1.6× 18 0.3× 30 0.6× 18 419
Afsar Mian Pakistan 12 144 0.9× 24 0.3× 30 0.4× 200 3.3× 31 0.6× 74 715
John L. Creech United States 9 84 0.5× 72 1.0× 44 0.6× 41 0.7× 41 0.9× 16 398
İbrahim Çevik Türkiye 12 21 0.1× 205 2.9× 41 0.6× 56 0.9× 31 0.6× 48 508
Winghing Wong United States 11 132 0.9× 16 0.2× 24 0.3× 198 3.3× 40 0.8× 17 579

Countries citing papers authored by David E. Joyner

Since Specialization
Citations

This map shows the geographic impact of David E. Joyner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David E. Joyner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David E. Joyner more than expected).

Fields of papers citing papers by David E. Joyner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David E. Joyner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David E. Joyner. The network helps show where David E. Joyner may publish in the future.

Co-authorship network of co-authors of David E. Joyner

This figure shows the co-authorship network connecting the top 25 collaborators of David E. Joyner. A scholar is included among the top collaborators of David E. Joyner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David E. Joyner. David E. Joyner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Joyner, David E., et al.. (2009). FAP-associated desmoid invasiveness correlates with in vitro resistance to doxorubicin. Familial Cancer. 8(4). 569–580. 5 indexed citations
2.
Joyner, David E., et al.. (2009). Potential for functional redundancy in EGF and TGFα signaling in desmoid cells: a cDNA microarray analysis. Growth Factors. 28(1). 10–23. 5 indexed citations
3.
Joyner, David E., et al.. (2009). Desmoid cell motility is induced in vitro by rhEGF. Journal of Orthopaedic Research®. 27(9). 1258–1262. 6 indexed citations
4.
Joyner, David E., Albert J. Aboulafia, Timothy A. Damron, & R. Lor Randall. (2008). Fas Death Pathway in Sarcomas Correlates with Epidermal Growth Factor Transcription. Clinical Orthopaedics and Related Research. 466(9). 2092–2098. 4 indexed citations
5.
Joyner, David E., Timothy A. Damron, Albert J. Aboulafia, & R. Lor Randall. (2007). Oncogene Coexpression in Mesenchymal Neoplasia Correlates with EGF Transcription. Clinical Orthopaedics and Related Research. 459. 14–21. 3 indexed citations
6.
Joyner, David E., et al.. (2006). Doxorubicin induces cell senescence preferentially over apoptosis in the FU‐SY‐1 synovial sarcoma cell line. Journal of Orthopaedic Research®. 24(6). 1163–1169. 26 indexed citations
7.
Joyner, David E., et al.. (2006). Heterogeneous expression of melanoma antigen (hMAGE) mRNA in mesenchymal neoplasia. Tissue Antigens. 68(1). 19–27. 5 indexed citations
8.
Joyner, David E., et al.. (2006). G3139 antisense oligonucleotide directed against antiapoptotic Bcl‐2 enhances doxorubicin cytotoxicity in the FU‐SY‐1 synovial sarcoma cell line. Journal of Orthopaedic Research®. 24(3). 474–480. 19 indexed citations
9.
Randall, R. Lor, et al.. (2005). Diagnosis and Management of Synovial Sarcoma. Current Treatment Options in Oncology. 6(6). 449–459. 24 indexed citations
10.
Randall, R. Lor, et al.. (2005). Transit Tumor Retrieval Preserves RNA Fidelity and Obviates Snap-Freezing. Clinical Orthopaedics and Related Research. &NA;(438). 149–157. 2 indexed citations
11.
Joyner, David E., Mark Wade, Anikó Szabó, et al.. (2004). Discriminate gene lists derived from cDNA microarray profiles of limited samples permit distinguishing mesenchymal neoplasia ex vivo. Journal of Cancer Research and Clinical Oncology. 131(3). 137–146. 5 indexed citations
12.
Randall, R. Lor, Mark Wade, Karen Albritton, & David E. Joyner. (2003). Retrieval Yield of Total and Messenger RNA in Mesenchymal Tissue Ex Vivo. Clinical Orthopaedics and Related Research. 415(415). 59–63. 7 indexed citations
13.
Randall, R. Lor, Mark Wade, Karen Albritton, Cheryl M. Coffin, & David E. Joyner. (2003). Validation of cDNA microarray analysis to distinguish tumor type ex vivo.. PubMed. S110–9. 7 indexed citations
14.
Knudtson, Kevin L., et al.. (1997). Expression of the superantigen Mycoplasma arthritidis mitogen in Escherichia coli and characterization of the recombinant protein. Infection and Immunity. 65(12). 4965–4971. 10 indexed citations
15.
Joyner, David E., et al.. (1987). Nutritional characteristics of grains fed to Canada Geese. Wildfowl (Wildfowl & Wetlands Trust). 38(38). 89–93. 21 indexed citations
16.
Rowley, R., et al.. (1987). In vitroresponse to hyperthermia or X-irradiation of diploid and tetraploid RIF-1 cells separated by centrifugal elutriation. International Journal of Hyperthermia. 3(3). 235–244. 6 indexed citations
17.
Joyner, David E., et al.. (1981). Pond ecology and its influence on Mallard use in Ontario, Canada. Wildfowl (Wildfowl & Wetlands Trust). 32(32). 28–34. 20 indexed citations
18.
Joyner, David E., et al.. (1981). Use of 4-Aminopyridine in Cornfields under High Foraging Stress. Journal of Wildlife Management. 45(3). 702–702. 4 indexed citations
19.
Joyner, David E.. (1978). Wing Molt in Female Ruddy Ducks. Ornithological Applications. 80(1). 102–102. 3 indexed citations
20.
Joyner, David E.. (1975). NEST PARASITISM AND BROOD-RELATED BEHAVIOR OF THE RUDDY DUCK (OXYURA JAMAICENSIS RUBIDA).. Journal of Colloid and Interface Science. 361(1). 212–8.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026